Giovanni Brandi
Giovanni Brandi
Affiliazione sconosciuta
Email verificata su unibo.it
TitoloCitata daAnno
Prevalence of and risk factors for hepatic steatosis in Northern Italy
S Bellentani, G Saccoccio, F Masutti, LS Crocè, G Brandi, F Sasso, ...
Annals of internal medicine 132 (2), 112-119, 2000
15202000
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses
V Gaboriau-Routhiau, S Rakotobe, E Lécuyer, I Mulder, A Lan, ...
Immunity 31 (4), 677-689, 2009
10882009
Drinking habits as cofactors of risk for alcohol induced liver damage
S Bellentani, G Saccoccio, G Costa, C Tiribelli, F Manenti, M Sodde, ...
Gut 41 (6), 845-850, 1997
7141997
Drinking habits as cofactors of risk for alcohol induced liver damage
S Bellentani, G Saccoccio, G Costa, C Tiribelli, F Manenti, M Sodde, ...
Gut 41 (6), 845-850, 1997
7141997
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double …
KM Zhu AX, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Chung ...
Lancet Oncology 16 (7), 859-70, 2015
3442015
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention
D Colussi, G Brandi, F Bazzoli, L Ricciardiello
International journal of molecular sciences 14 (8), 16365-16385, 2013
3202013
Interactions between commensal bacteria and gut sensorimotor function in health and disease
G Barbara, V Stanghellini, G Brandi, C Cremon, G Di Nardo, R De Giorgio, ...
The American journal of gastroenterology 100 (11), 2560, 2005
2582005
Clinical patterns of hepatocellular carcinoma (hcc) in non alcoholic fatty liver disease (NAFLD): A multicenter prospective study
BS Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S ...
Hepatology, 2015
215*2015
High prevalence of celiac disease in Italian general population
U Volta, S Bellentani, FB Bianchi, G Brandi, L De Franceschi, L Miglioli, ...
Digestive diseases and sciences 46 (7), 1500-1505, 2001
1952001
Hypersensitivity reactions related to oxaliplatin (OHP)
G Brandi, MA Pantaleo, C Galli, A Falcone, A Antonuzzo, P Mordenti, ...
British journal of cancer 89 (3), 477, 2003
1372003
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment?
M Di Marco, R Di Cicilia, M Macchini, E Nobili, S Vecchiarelli, G Brandi, ...
Oncology reports 23 (5), 1183-1192, 2010
1312010
Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas
GM Paganelli, G Biasco, G Brandi, R Santucci, G Gizzi, V Villani, M Cianci, ...
JNCI: Journal of the National Cancer Institute 84 (1), 47-52, 1992
1281992
Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties
G Biasco, E Derenzini, GL Grazi, G Ercolani, M Ravaioli, MA Pantaleo, ...
Cancer treatment reviews 32 (3), 214-228, 2006
1212006
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival
G Ercolani, G Vetrone, GL Grazi, O Aramaki, M Cescon, M Ravaioli, ...
Annals of surgery 252 (1), 107-114, 2010
1202010
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo …
AX Zhu, YK Kang, CJ Yen, RS Finn, PR Galle, JM Llovet, E Assenat, ...
The Lancet Oncology 20 (2), 282-296, 2019
972019
Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients
G Liguori, B Lamas, ML Richard, G Brandi, G Da Costa, TW Hoffmann, ...
Journal of Crohn's and Colitis 10 (3), 296-305, 2015
872015
Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?
M Renzulli, S Brocchi, A Cucchetti, F Mazzotti, C Mosconi, C Sportoletti, ...
Radiology 279 (2), 432-442, 2015
832015
REACH-2: A randomized, double-blind, placebo-controlled phase 3 study of ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma …
AX Zhu, YK Kang, CJ Yen, RS Finn, PR Galle, JM Llovet, E Assenat, ...
Journal of Clinical Oncology 36 (15_suppl), 4003-4003, 2018
802018
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia
M Renga, G Brandi, GM Paganelli, C Calabrese, S Papa, A Tosti, ...
Gut 41 (3), 330-332, 1997
781997
Intestinal microflora and digestive toxicity of irinotecan in mice.
G Brandi, J Dabard, P Raibaud, M Di Battista, C Bridonneau, AM Pisi, ...
Clinical cancer research 12 (4), 1299-1307, 2006
702006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20